Skip to content

Author

Stephen Y. Lai

We have 2 of 42 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact

This position article synthesizes key barriers in ICI therapy while highlighting emerging opportunities to refine patient selection, improve safety, and enhance therapeutic durability, position the field to move beyond the current plateau toward a more precise, effective, and patient-centered era of immuno-oncology.

Joud Hajjar, B. Stephen, A. Aaroe et al. · 1 citation
Open access Aug 2026

TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.

The findings of this cohort study suggest that the high prevalence of TERT promoter variants in older patients largely explains the association between age and worse prognosis in PTC.

V. R. Marczyk, Sophie Li, Chia C. Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.